Browse > Article
http://dx.doi.org/10.7314/APJCP.2016.17.1.219

Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma  

Khor, Goot Heah (Centre of Preclinical Science Studies, Faculty of Dentistry, Universiti Teknologi MARA, Sungai Buluh Campus)
Froemming, Gabrielle Ruth Anisah (Institute of Pathology, Laboratory and Forensic Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buluh Campus)
Zain, Rosnah Binti (Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya)
Abraham, Thomas Mannil (Tengku Ampuan Rahimah Hospital, Department of Oral and Maxillofacial Surgery, Ministry of Health Malaysia)
Lin, Thong Kwai (Institute of Biological Science, Faculty of Science, University of Malaya)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.17, no.1, 2016 , pp. 219-223 More about this Journal
Abstract
Background: Promoter hypermethylation is a frequent epigenetic mechanism for gene transcription repression in cancer and is one of the hallmarks of the disease. Cadherin EGF LAG seven-pass G-type receptor 3 (CELSR3) contributes to cell contact-mediated communication. Dysregulation of promoter methylation has been reported in various cancers. Objectives: The objectives of this study were to investigate the CELSR3 hypermethylation level in oral squamous cell carcinomas (OSCCs) using methylation-sensitive high-resolution melting analysis (MS-HRM) and to correlate CELSR3 methylation with patient demographic and clinicopathological parameters. Materials and Methods: Frozen tissue samples of healthy subjects' normal mucosa and OSCCs were examined with regard to their methylation levels of the CELSR3 gene using MS-HRM. Results: MS-HRM analysis revealed a high methylation level of CELSR3 in 86% of OSCC cases. Significant correlations were found between CELSR3 quantitative methylation levels with patient ethnicity (P=0.005), age (P=0.024) and pathological stages (P=0.004). A moderate positive correlation between CELSR3 and patient age was also evident (R=0.444, P=0.001). Conclusions: CELSR3 promoter hypermethylation may be an important mechanism involved in oral carcinogenesis. It may thus be used as a biomarker in OSCC prognostication.
Keywords
CELSR3; hypermethylation; oral squamous cell carcinoma; biomarker;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Khor GH, Froemming GRA, Zain RB, et al (2013). DNA methylation profiling revealed promoter hypermethylationinduced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma. Inter J Med Sci, 10, 1727-39.   DOI
2 Khor GH, Froemming GRA, Zain RB, et al (2014). Screening of differential promoter hypermethylated genes in primary oral squamous cell carcinoma. Asian Pacific J Cancer Prev, 15, 8957-61.   DOI
3 Mascolo M, Siano M, Ilardi G, et al (2012). Epigenetic disregulation in oral cancer. Int J Mol Sc, 13, 2331-53.   DOI
4 Montgomery JL, Sanford LN, Wittwer CT (2010). Highresolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn, 10, 219-40.   DOI
5 Morris MR, Ricketts CJ, Gentle D, et a (2010). Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene, 30, 1390-401.
6 Pimenta Amaral TM, da Silva Freire AR, Carvalho AL, et al (2004). Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol, 40, 780-6.   DOI
7 Reed GH, Kent JO, Wittwer CT (2007). High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics, 8, 597-608.   DOI
8 Shen J, Wang S, Zhang YJ, et al (2012). Genome wide DNA methylation profiles in hepatocellular carcinoma. Hepatology, 55, 1799-808.   DOI
9 Tian XY, Zhang L, Sun LG, et al (2015). Epigenetic Regulation of miR-129-2 Leads to Overexpression of PDGFRa and FoxP1 in Glioma Cells. Asian Pac J Cancer Prev, 16, 6129-33.   DOI
10 Tissir F, Bar I, Jossin Y, et al (2005). Protocadherin Celsr3 is crucial in axonal tract development. Nature Neurosci, 8, 451-7.   DOI
11 Wittwer CT (2009). High-resolution DNA melting analysis. advancements and limitations. Hum Mutat, 30, 857-9.   DOI
12 Wojdacz TK, Dobrovic A (2007). Methylation-sensitive high resolution melting (MS-HRM), a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res, 35, 41.   DOI
13 Wojdacz TK, Dobrovic A, Hansen LL (2008). Methylationsensitive high-resolution melting. Nature Protoc, 3, 1903-8.   DOI
14 Wojdacz TK, Borgbo T, Hansen LL (2009). Primer design versus PCR bias in methylation independent PCR amplifications. Epigenetics, 4, 231-4.   DOI
15 Wojdacz TK, Moller TH, Thestrup BB, et al (2010). Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies. Expert Rev Mol Diagn, 10, 575-80.   DOI
16 Einav Nili GY, Saito Y, Egger G, et al (2008). Cancer epigenetics, modifications, screening, and therapy. Annu Rev Med, 59, 267-80.   DOI
17 Amornpisutt R, Sriraksa R, Limpaiboon T (2012). Validation of methylation-sensitive high resolution melting for the detection of DNA methylation in cholangiocarcinoma. Clin Biochem, 45, 1092-4.   DOI
18 Baylin SB, Ohm JE (2006). Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nature Rev Cancer, 6, 107-16.   DOI
19 Cianfrocca M, Goldstein LJ (2004). Prognostic and predictive factors in early-stage breast cancer. The Oncologist, 9, 606-16.   DOI
20 Dobrowolski SF, Wittwer CT (2011). High-resolution melt profiling, in molecular analysis and genome discovery. John Wiley & Sons, Ltd, p. 81-113.
21 Erkan M, Weis N, Pan Z, et al (2010). Organ-, inflammation-and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer, 9, 88-103.   DOI
22 Feng, J, Han Q, Zhou L (2012). Planar cell polarity genes, Celsr1-3 in neural development. Neurosci Bulletin, 28, 39-15.   DOI
23 Herman JG, Baylin SB (2003). Gene silencing in cancer in association with promoter hypermethylation. New Engl J Med, 349, 2042-54.   DOI
24 Jemal A, Siegel R, Ward E (2007). Ca_statistica. CA Cancer J Clin, 57, 43-66.   DOI
25 Jeong P, Ha YS, Cho IC, et al (2011). Three-gene signature predicts disease progression of non-muscle invasive bladder cancer. Oncol Lett, 2, 679-84.   DOI
26 Katoh M (2005). WNT/PCP signaling pathway and human cancer (Review). Oncol Reports, 14, 1583-8.
27 Katoh M, Katoh M (2007). Comparative integromics on noncanonical WNT or planar cell polarity signaling molecules, Transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells. Inter J Mol Med, 20, 405-9.